Table 1 Summary of the anti-NPM1 antibodies working in different immunotechniques and reported in the literature

From: The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients

Immunological application

Clone name; epitope location

Reference

IF, IHC

NA24, NPMa, NPMc (monoclonals); A- and C-terminals

Cordell et al.4

IHC

322, 376 (monoclonals); N-terminal

Falini et al.2

IF, IHC

SilA (rabbit polyclonal); N-terminal

Quentmeier et al.7

WB, IP

IF, IHC

SilC (rabbit polyclonal); C-terminal

322, 376 (monoclonals); N-terminal

Falini et al.5

WB

SilA, SilC (rabbit polyclonals); N- and C-terminals

Martelli et al.8

IF

FC-61991 (monoclonal, Invitrogen, Camarillo, CA, USA)

Colombo et al.10

IHC

376 (monoclonal); N-terminal

Konoplev et al.12

IHC

376 (monoclonal); N-terminal

Luo et al.6

IF

IHC

376 (monoclonal); N-terminal

NA24 (monoclonal); N-terminal

Mattsson et al.13

FC

5E3, (monoclonal); C-terminal

Oelschlaegel et al.3

IF, FC

T26 (monoclonal); C-terminal

Gruszka et al.9

  1. Abbreviations: C-terminal, carboxty terminal; FC, flow cytometry; IF, immunofluorecsence; IHC, immunohistochemistry; IP, immunoprecipitation; N-terminal, animo terminal; NPM1, nucleophosmin 1; WB, western blot.